Literature DB >> 7870879

Caffeine and nicotine improve visual tracking by rats: a comparison with amphetamine, cocaine and apomorphine.

J L Evenden1, M Turpin, L Oliver, C Jennings.   

Abstract

Psychomotor stimulant drugs such as caffeine, nicotine, amphetamine and cocaine, have been shown to improve vigilance in man under conditions of fatigue. Nicotine has also been shown to improve performance in some cognitive tests in patients with Alzheimer's disease. In rodents these drugs increase activity which may confound "performance enhancing effects" in rodent models. However, improvements have been found in a number of tests that do not seem to be directly dependent upon an enhancement of locomotor activation. In one example, Evenden and Robbins (1985) reported consistent improvements in a visual tracking test following amphetamine. The present study was undertaken to determine whether these performance enhancing effects of amphetamine could also be obtained with cocaine and apomorphine, which both have psychomotor stimulant effects through their actions as, respectively, indirect and direct dopamine agonists, and by caffeine and nicotine, which do not have a direct dopaminergic mechanism of action. The results of the study indicate that all five drugs improved tracking performance at one or more doses. The most consistent effects were obtained with amphetamine which, like cocaine and nicotine, improved tracking at a dose which did not produce other changes in behaviour. Taking into account previous studies (Evenden and Robbins 1983, 1985), these results were interpreted as indicating that psychomotor stimulant drugs produce a general activation of behaviour. At all but the highest doses of such drugs, the form of behaviour that is observed depends upon the environment.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7870879     DOI: 10.1007/bf02246968

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  21 in total

1.  Enhancement of human performance by caffeine and the amphetamines.

Authors:  B WEISS; V G LATIES
Journal:  Pharmacol Rev       Date:  1962-03       Impact factor: 25.468

2.  Odor detection performance of rats following d-amphetamine treatment: a signal detection analysis.

Authors:  R L Doty; M Ferguson-Segall
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  6-Hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbens d-amphetamine.

Authors:  J R Taylor; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Scopolamine and the control of attention in humans.

Authors:  M P Dunne; L R Hartley
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  The acquisition of responding with conditioned reinforcement: effects of pipradrol, methylphenidate, d-amphetamine, and nomifensine.

Authors:  T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1978-06-15       Impact factor: 4.530

6.  Psychotropic effects of caffeine in man. II. Alertness, psychomotor coordination, and mood.

Authors:  A Goldstein; S Kaizer; R Warren
Journal:  J Pharmacol Exp Ther       Date:  1965-10       Impact factor: 4.030

7.  Intravenous nicotine in Alzheimer's disease: a pilot study.

Authors:  P A Newhouse; T Sunderland; P N Tariot; C L Blumhardt; H Weingartner; A Mellow; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 8.  Smoking, nicotine and human performance.

Authors:  K Wesnes; D M Warburton
Journal:  Pharmacol Ther       Date:  1983       Impact factor: 12.310

9.  Amphetamine effects on poor performance of rats in a shuttle-box.

Authors:  R H Rech
Journal:  Psychopharmacologia       Date:  1966

10.  Contrasting interactions of pipradrol, d-amphetamine, cocaine, cocaine analogues, apomorphine and other drugs with conditioned reinforcement.

Authors:  T W Robbins; B A Watson; M Gaskin; C Ennis
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more
  3 in total

1.  Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatment.

Authors:  Nurith Amitai; Athina Markou
Journal:  Pharmacol Biochem Behav       Date:  2008-09-08       Impact factor: 3.533

2.  Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administration.

Authors:  Nurith Amitai; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2008-07-11       Impact factor: 4.530

3.  Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands.

Authors:  J McGaughy; M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.